DS-7113b injection phase II/III study An open label and extension study of DS-7113 injection in patients with cancer pain (intravenous administration)
Latest Information Update: 28 Jun 2016
At a glance
- Drugs Hydromorphone (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 27 Jun 2016 Status changed from active, no longer recruiting to completed.
- 09 Jun 2016 New trial record